@article{9a71e8567d6c4e2980b5227cd28fbe96,
title = "Why an M1 Antagonist Could Be a More Selective Model for Memory Impairment than Scopolamine",
keywords = "actelylcholine, Alzheimer, cognition enhancer, memory, deficit model, MUSCARINIC ACETYLCHOLINE-RECEPTOR, PSYCHOMOTOR PERFORMANCE, COGNITIVE PERFORMANCE, ALZHEIMERS-DISEASE, M-1, LORAZEPAM, XANOMELINE, MODULATION, AGONIST, DRUGS",
author = "Arjan Blokland and Anke Sambeth and Jos Prickaerts and Riedel, {Wim J}",
year = "2016",
month = sep,
day = "30",
doi = "10.3389/fneur.2016.00167",
language = "English",
volume = "7",
journal = "Frontiers in Neurology",
issn = "1664-2295",
publisher = "Frontiers Media S.A.",
}